findmyKOL
Clinical trialNCT03221257CompletedPhase 2Interventional

Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate

SponsorMichael RothEnrollment51Interstitial Lung DiseaseScleroderma, Systemic
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Michael D Roth, MD

    Pulmonary & Critical Care Medicine, Geffen School of Medicine at UCLA

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California Los Angeles

    Los Angeles, California, United States

  • University of Colorado

    Aurora, Colorado, United States

  • Georgetown University

    Washington D.C., District of Columbia, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Indiana University Health

    Indianapolis, Indiana, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Boston University, School of Medicine

    Boston, Massachusetts, United States

  • Harvard Medical School, Brigham & Women'S Hospital

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Rutgers University

    New Brunswick, New Jersey, United States

  • Hospital for Special Surgery

    New York, New York, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • University of Texas Medical School at Houston

    Houston, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

  • University of Washington Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Nov 2017
Primary completion
23 Mar 2022
Completion
13 Jun 2022
Last update posted
15 Dec 2023
Registered enrollment
51
Registry id
NCT03221257

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.